Treatment of liver diseases in which iron plays a role in pathogenesis

Details for Australian Patent Application No. 2006252718 (hide)

Owner Novartis AG

Inventors Marks, Peter; Nick, Hanspeter; Rojkjaer, Lisa Grace; Alberti, Daniele

Agent Davies Collison Cave

Pub. Number AU-B-2006252718

PCT Pub. Number WO2006/130532

Priority 60/746,786 09.05.06 US; 60/692,808 22.06.05 US; 60/685,848 31.05.05 US

Filing date 30 May 2006

Wipo publication date 7 December 2006

Acceptance publication date 15 April 2010

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/130532 Priority application(s): WO2006/130532

15 April 2010 Application Accepted

  Published as AU-B-2006252718

12 August 2010 Standard Patent Sealed

12 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006252725-Restrictor and dispensing system

2006252708-Methods and compositions for managing psychotic disorders